Table 2.
Variable | N | % | α | Mean | (SD) |
---|---|---|---|---|---|
Criterion: | |||||
Depressive Symptoms (CES-D) | |||||
Pre-treatment | 187 | .908 | 12.95 | (10.25) | |
Post-treatment | 144 | .917 | 10.70 | (9.91) | |
6 Month Follow-up | 178 | .924 | 12.06 | (10.80) | |
12 Month Follow-up | 176 | .911 | 11.52 | (9.76) | |
18 Month Follow-up | 172 | .916 | 11.14 | (10.00) | |
Clinically Significant Depressive Symptoms (CES-D ≥ 16) | |||||
Pre-treatment | 63 | 33.69 % | |||
Post-treatment | 38 | 26.39 % | |||
6 Month Follow-up | 54 | 30.34 % | |||
12 Month Follow-up | 44 | 25.00 % | |||
18 Month Follow-up | 45 | 26.16 % | |||
Clinically Significant Depressive Symptoms (CES-D ≥ 20) | |||||
Pre-treatment | 42 | 22.46 % | |||
Post-treatment | 26 | 18.06 % | |||
6 Month Follow-up | 38 | 21.35 % | |||
12 Month Follow-up | 34 | 19.32 % | |||
18 Month Follow-up | 29 | 16.86 % | |||
Predictor: | |||||
CRP (mg/L) | |||||
Pre-treatment | 185 | 3.44 | (5.25) | ||
Post-treatment | 144 | 3.74 | (7.85) | ||
6 Month Follow-up | 168 | 2.41 | (3.76) | ||
12 Month Follow-up | 159 | 2.30 | (3.60) | ||
18 Month Follow-up | 159 | 2.56 | (4.45) | ||
Stress Moderators: | |||||
Cancer-related Intrusive Thoughts (IES) | |||||
Pre-treatment | 187 | .898 | 1.78 | (1.35) | |
Post-treatment | 144 | .909 | 1.12 | (1.18) | |
6 Month Follow-up | 177 | .903 | 1.21 | (1.18) | |
12 Month Follow-up | 176 | .884 | 1.15 | (1.11) | |
18 Month Follow-up | 172 | .892 | 1.08 | (1.09) | |
General stress perceptions (PSS) | |||||
Pre-treatment | 187 | .876 | 15.50 | (6.63) | |
Post-treatment | 144 | .909 | 13.16 | (6.98) | |
6 Month Follow-up | 178 | .925 | 14.87 | (7.68) | |
12 Month Follow-up | 176 | .912 | 14.52 | (7.04) | |
18 Month Follow-up | 172 | .907 | 14.46 | (7.25) | |
Childhood stress (CTQ) | 184 | .928 | 37.24 | (14.13) |
CES-D = Center for Epidemiological Studies – Depression; CRP = C-reactive Protein; IES = Impact of Event Scale; PSS = Perceived Stress Scale; CTQ = Childhood Trauma Questionnaire.